Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mounjaro First Month Results According to clinical trials, on an average you can lose up to 4% of your body weight after one month and 6% after two months
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has raised questions about potential cognitive effects
By partnering with our expert team at the Michael Horn Plastic Surgery & Lumire Medspa, you can expect the following benefits: Significant weight loss, especially when combined with a healthy diet and exercise routine
DiPietro, L., et al
Methods The Peptide Innovation for Early Diabetes Treatment (PIONEER) 12 trial was a randomised, double-dummy, active-controlled, parallel-group, Phase IIIa trial conducted over 26 weeks at 90 sites across the China region (including mainland China, Taiwan and Hong Kong) and five other countries
1 Diabetes is a chronic condition that affects how the body regulates blood sugar levels
US$ 21.21
US$ 24.53
US$ 25.47
